Fulgent Genetics, Inc. (FLGT)

USD 20.54

(19.07%)

Total Assets Summary of Fulgent Genetics, Inc.

  • Fulgent Genetics, Inc.'s latest annual total assets in 2023 was 1.27 Billion USD , down -8.15% from previous year.
  • Fulgent Genetics, Inc.'s latest quarterly total assets in 2024 Q1 was 1.22 Billion USD , down -3.4% from previous quarter.
  • Fulgent Genetics, Inc. reported annual total assets of 1.38 Billion USD in 2022, up 8.39% from previous year.
  • Fulgent Genetics, Inc. reported annual total assets of 1.27 Billion USD in 2021, up 82.55% from previous year.
  • Fulgent Genetics, Inc. reported quarterly total assets of 1.23 Billion USD for 2024 Q2, up 0.19% from previous quarter.
  • Fulgent Genetics, Inc. reported quarterly total assets of 1.35 Billion USD for 2023 Q2, down -1.61% from previous quarter.

Annual Total Assets Chart of Fulgent Genetics, Inc. (2023 - 2001)

Historical Annual Total Assets of Fulgent Genetics, Inc. (2023 - 2001)

Year Total Assets Total Assets Growth
2023 1.27 Billion USD -8.15%
2022 1.38 Billion USD 8.39%
2021 1.27 Billion USD 82.55%
2020 700.46 Million USD 689.2%
2019 88.75 Million USD 61.33%
2018 55.01 Million USD -3.4%
2017 56.95 Million USD -1.88%
2016 58.04 Million USD 895.2%
2015 5.83 Million USD 175.09%
2014 2.12 Million USD 0.0%
2001 1.27 Billion USD 0.0%

Peer Total Assets Comparison of Fulgent Genetics, Inc.

Name Total Assets Total Assets Difference
Aclaris Therapeutics, Inc. 197.4 Million USD -544.922%
Applied DNA Sciences, Inc. 13.65 Million USD -9225.728%
Aspira Women's Health Inc. 6.26 Million USD -20230.709%
Biodesix, Inc. 99.09 Million USD -1184.723%
BioNexus Gene Lab Corp. 11.39 Million USD -11067.826%
bioAffinity Technologies, Inc. 8.22 Million USD -15385.02%
bioAffinity Technologies, Inc. 8.22 Million USD -15385.02%
Bionano Genomics, Inc. 214.4 Million USD -493.79%
CareDx, Inc 484.61 Million USD -162.705%
Check-Cap Ltd. 25.01 Million USD -4988.975%
Castle Biosciences, Inc. 477.81 Million USD -166.446%
DarioHealth Corp. 96.38 Million USD -1220.803%
Exact Sciences Corporation 6.47 Billion USD 80.327%
Guardant Health, Inc. 1.78 Billion USD 28.734%
ICON Public Limited Company 16.98 Billion USD 92.507%
IDEXX Laboratories, Inc. 3.25 Billion USD 60.947%
Illumina, Inc. 10.11 Billion USD 87.409%
Intelligent Bio Solutions Inc. 13.77 Million USD -9139.579%
iSpecimen Inc. 15.81 Million USD -7947.904%
Standard BioTools Inc. 323.06 Million USD -294.07%
MDxHealth SA 129.13 Million USD -885.897%
23andMe Holding Co. 395.16 Million USD -222.17%
Medpace Holdings, Inc. 1.65 Billion USD 23.16%
Myriad Genetics, Inc. 1.19 Billion USD -6.207%
Mainz Biomed B.V. 15.4 Million USD -8162.098%
ENDRA Life Sciences Inc. 6.75 Million USD -18749.296%
NeoGenomics, Inc. 1.68 Billion USD 24.275%
Neogen Corporation 4.58 Billion USD 72.228%
Inotiv, Inc. 856.53 Million USD -48.636%
Natera, Inc. 1.45 Billion USD 12.629%
OPKO Health, Inc. 2.01 Billion USD 36.715%
Psychemedics Corporation 13.27 Million USD -9493.888%
Prenetics Global Limited 254.17 Million USD -400.888%
Prenetics Global Limited 254.17 Million USD -400.888%
Precipio, Inc. 18.1 Million USD -6933.363%
Personalis, Inc. 225.09 Million USD -465.577%
RadNet, Inc. 2.88 Billion USD 55.897%
Sera Prognostics, Inc. 95.44 Million USD -1233.923%
Sotera Health Company 3.13 Billion USD 59.331%
Neuronetics, Inc. 115.83 Million USD -999.109%
Star Equity Holdings, Inc. 86.97 Million USD -1363.781%
Star Equity Holdings, Inc. 86.97 Million USD -1363.781%
Trinity Biotech plc 59.43 Million USD -2042.019%
Twist Bioscience Corporation 776.4 Million USD -63.975%
Exagen Inc. 56.94 Million USD -2135.721%